Inventor · disambiguated record
Jason Gordon Weatherhead
Also filed as: WEATHERHEAD JASON · WEATHERHEAD JASON G · WEATHERHEAD JASON GORDON
16 granted patents·10 pending applications·35 citations·filing 2005–2024
90Inventor score
Files withVIIV HEALTHCARE UK LTD9SHIONOGI & CO6GLAXOSMITHKLINE IP DEV LTD3JOHNS BRIAN ALVIN3VIIV HEALTHCARE CO3
Top patents by PatentIndex Score
26 records- 0192US8580967B2Methyl 3-(benzyloxy)-1-(2,2-dihydroxyethyl)-4-oxo-1,4-dihydropyridine-2-carboxylate and processes for the preparation thereofJOHNS BRIAN ALVIN·Filed 2009·Granted Nov 12, 2013·8 cites·3 claims
- 0289US8217034B2Chemical compoundsJOHNS BRIAN ALVIN·Filed 2009·Granted Jul 10, 2012·18 cites·10 claims
- 0385US9012650B2Substituted (3S, 11aR)-N-[(2,4-difluorophenyl)methyl]-6-oxy-3-methyl-5,7-dioxo-2,3,5,7,11,11a-hexahydro[1,3]oxazolo[3,2-a]pyrido[1,2-d]pyrazine-8-carboxamides of formula (I) useful as HIV agentsSHIONOGI & CO·Filed 2014·Granted Apr 21, 2015·2 cites·10 claims
- 0475US2025066361A15,6,7,7a-Tetrahydrocyclopenta[f]pyrido[1,2-h][1,7] naphthyridin-11(4bH)-one Compounds and Methods of use Use (as amended)GLAXOSMITHKLINE IP DEV LTD·Filed 2024·Application pending·0 cites
- 0572US8765965B21-(2,3-dihydroxypropyl)-4-oxo-3-[(phenylmethyl)oxy]-1,4-dihydro-2-pyridinecarboxylic acid of the formula P-6 and/or methyl 1-(2,3-dihydroxypropyl)-4-oxo-3-[(phenylmethyl)oxy]-1,4-dihydro-2-pyridinecarboxylate of the formula P-7VIIV HEALTHCARE CO·Filed 2013·Granted Jul 1, 2014·0 cites·2 claims
- 0672US8691991B22-oxonaphthyridine-3-carboxamides HIV integrase inhibitorsJOHNS BRIAN ALVIN·Filed 2005·Granted Apr 8, 2014·2 cites·22 claims
- 0771US8981129B22-(2-hydroxy-2-phenylethyl)-3-[(phenylmethyl)oxy]-4H-pyran-4-one of the formula P-3 and/or 2-[(E)-2-phenylethenyl]-3-[(phenylmethyl)oxy]-4H-Pyran-4-one of the formula P-4SHIONOGI & CO·Filed 2014·Granted Mar 17, 2015·0 cites·2 claims
- 0870US8609653B2Azaindole compounds and methods for treating HIVDE LA ROSA MARTHA ALICIA·Filed 2012·Granted Dec 17, 2013·3 cites·11 claims
- 0967US8940912B24-oxo-3-[(phenylmethyl)oxy]-4H-pyran-2-carboxylic acidVIIV HEALTHCARE CO·Filed 2013·Granted Jan 27, 2015·0 cites·1 claims
- 1065US12221444B25,6,7,7a-tetrahydrocyclopenta[f]pyrido[1,2-h][1,7]naphthyridin-11(4bH)-one compounds and methods of useGLAXOSMITHKLINE INTELLECTUAL·Filed 2021·Granted Feb 11, 2025·0 cites·9 claims
- 1165US9707246B2Substituted (3S,11AR)-N-[(2,4-difluorophenyl)methyl]-6-oxy-3-methyl-5,7-dioxo-2,3,5,7,11,11A-hexahydro[1,3]oxazolo[3,2-A]pyrido[1,2-D]pyrazine-8-carboxamides as HIV agentsSHIONOGI & CO·Filed 2015·Granted Jul 18, 2017·0 cites·4 claims
- 1264US9163023B2Compounds and methods for treating HIVVIIV HEALTHCARE UK LTD·Filed 2013·Granted Oct 20, 2015·1 cites·17 claims
- 1363US10112899B2Isoindoline derivatives for use in the treatment of a viral infectionVIIV HEALTHCARE UK LTD·Filed 2015·Granted Oct 30, 2018·1 cites·13 claims
- 1460US9133216B2(3S,11aR)-6-[(phenylmethyl)oxy]-3-methyl-2,3,11,11a-tetrahydrooxazolo[3,2-a]pyrido[1,2-d]pyrazine-5,7-dione of the formula P-9 and/or (3S,11aR)-6-[(phenymethyl)oxy]-8-bromo-3-methyl-2,3,11,11a-tetrahydrooxazolo[3,2-a]pyrido[1,2-d]pyrazine-5,7-dione of the formula P-10SHIONOGI & CO·Filed 2015·Granted Sep 15, 2015·0 cites·2 claims
- 1558US8691823B2Prodrugs of (4aS, 13ar)-N-[(2,4-difluorophenyl)methyl]-10-hydroxy-9-11-dioxo-2,3,4a,5,9,11,13,13a-octahydro-1H-pyrido[1,2-a]pyrrolo[1′,2′:3:4]imidazo[1,2-d]pyrazine-8-carboxamide and their use in the treatment of HIV infectionSHIONOGI & CO·Filed 2013·Granted Apr 8, 2014·0 cites·10 claims
- 1655US2014256713A12-oxonaphthyridine-3-carboxamides hiv integrase inhibitorsSHIONOGI & CO·Filed 2014·Application pending·0 cites
- 1753US2020255428A1Chemical compoundsGLAXOSMITHKLINE IP DEV LTD·Filed 2018·Application pending·0 cites
- 1845US2015225399A1Hiv integrase inhibitorsVIIV HEALTHCARE CO·Filed 2015·Application pending·0 cites
- 1939US10239840B2Benzoazepine derivativesVIIV HEALTHCARE UK LTD·Filed 2016·Granted Mar 26, 2019·0 cites·11 claims
- 2038US2019284136A1Indoline derivativesVIIV HEALTHCARE UK LTD·Filed 2017·Application pending·0 cites
- 2137US2019328900A1Antibody-drug conjugates and therapeutic methods using the sameGLAXOSMITHKLINE IP DEV LTD·Filed 2017·Application pending·0 cites
- 2237US2020255411A1Isoindoline derivativesVIIV HEALTHCARE UK LTD·Filed 2016·Application pending·0 cites
- 2336US2018334436A1Tetrahydroisoquinoline derivativesVIIV HEALTHCARE UK LTD·Filed 2016·Application pending·0 cites
- 2436US2018334453A1Isoindoline derivativesVIIV HEALTHCARE UK LTD·Filed 2016·Application pending·0 cites
- 2536US2018327355A1Isoindoline derivativesVIIV HEALTHCARE UK LTD·Filed 2016·Application pending·0 cites
- 2634US10118894B2Isoindolinone derivatives useful as antiviral agentsVIIV HEALTHCARE UK LTD·Filed 2015·Granted Nov 6, 2018·0 cites·9 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →